SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reshef Liron

(Last)

(First)

(Middle)

13 RIMON

(Street)

MOSHAV GEALIA

7688500

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP Human Resources

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Ordinary Shares⁽¹⁾	03/02/2024	09/02/2029	Ordinary Shares	10,000	$5.33⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	03/02/2025	09/02/2029	Ordinary Shares	10,000	$5.33⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	03/02/2026	09/02/2029	Ordinary Shares	10,000	$5.33⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2026	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	03/02/2027	09/02/2029	Ordinary Shares	10,000	$5.33⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2027	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2028	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2029	10/22/2035	Ordinary Shares	15,000	$7.55⁽²⁾	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Liron Reshef	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.